PEG3 and Hepatic fibrosis: Of them, two pathways (neuroinflammation signaling and IL-8 signaling) were enriched in all six sets and four (inhibition of matrix metalloproteases, hepatic fibrosis, apoptosis signaling, and docosahexaenoic acid (DHA) signaling) in four sets of the first group (pw1, pw2, pw1&2, and AlbU).